Walter KAMM,Till BUSSEMER,Doris ANDERT,Bernd KUEHN,Ernst-Josef TODT
申请号：
US15265191
公开号：
US20170224668A1
申请日:
2016.09.14
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino} butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
